Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Aug;52(8):1863–1870. doi: 10.1172/JCI107369

Measurement of Inorganic Pyrophosphate in Biological Fluids, ELEVATED LEVELS IN SOME PATIENTS WITH OSTEOARTHRITIS, PSEUDOGOUT, ACROMEGALY, AND UREMIA

Donald C Silcox 1, Daniel J McCarty 1
PMCID: PMC302467  PMID: 4352576

Abstract

A rapid and relatively simple method for measurement of inorganic pyrophosphate (PPi) in biological samples has been described. The mean ±SEM of plasma samples from 94 normal subjects was 1.8±0.06 μM, giving a normal range (99% confidence limits) of 0.16 - 3.40 μmol/liter. Analysis of 17 plasma samples in duplicate showed a standard deviation of 0.18, giving a 99% probability that a single determination of plasma PPi would be ±0.68 μM of the true value.

The mean PPi levels in plasma from subjects with osteoarthritis, pseudogout, acromegaly, and uremia were significantly greater than the normal mean (P < 0.01). Samples from rheumatoid arthritis showed PPi levels distributed about a mean identical to the normal mean. Plasma inorganic orthophosphate levels correlated positively with PPi levels in samples from normal subjects and in samples from patients with osteoarthritis, pseudogout, and uremia, but not with acromegaly. This correlation was statistically significant only in the normal samples and in those from patients with osteoarthritis.

Full text

PDF
1863

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CORVILAIN J., ABRAMOW M., BERGANS A. Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man. J Clin Invest. 1962 Jun;41:1230–1235. doi: 10.1172/JCI104584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. FLEISCH H., BISAZ S. Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol. 1962 Oct;203:671–675. doi: 10.1152/ajplegacy.1962.203.4.671. [DOI] [PubMed] [Google Scholar]
  3. FLYNN R. M., JONES M. E., LIPMANN F. A colorimetric determination of inorganic pyrophosphate. J Biol Chem. 1954 Dec;211(2):791–796. [PubMed] [Google Scholar]
  4. Flodgaard H. Isotope derivative method for determination of microquantities of inorganic pyrophosphate in biological material. Eur J Biochem. 1970 Aug;15(2):273–279. doi: 10.1111/j.1432-1033.1970.tb01004.x. [DOI] [PubMed] [Google Scholar]
  5. Grindey G. B., Nichol C. A. Micro procedure for determination of pyrophosphate and orthophosphate. Anal Biochem. 1970 Jan;33(1):114–119. doi: 10.1016/0003-2697(70)90444-6. [DOI] [PubMed] [Google Scholar]
  6. Johnson J. C., Shanoff M., Bass S. T., Boezi J. A., Hansen R. G. An enzymic method for determination of inorganic pyrophosphate and its use as an assay for RNA polymerase. Anal Biochem. 1968 Oct 10;26(1):137–145. doi: 10.1016/0003-2697(68)90037-7. [DOI] [PubMed] [Google Scholar]
  7. KOHN N. N., HUGHES R. E., McCARTY D. J., Jr, FAIRES J. S. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals. Ann Intern Med. 1962 May;56:738–745. doi: 10.7326/0003-4819-56-5-738. [DOI] [PubMed] [Google Scholar]
  8. KUNITZ M. Hydrolysis of adenosine triphosphate by crystalline yeast pyrophosphatase. Effect of zinc and magnesium ions. J Gen Physiol. 1962 Mar;45(4):31–46. doi: 10.1085/jgp.45.4.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lamotte M., Segrestaa J. M., Krassinine G. Arthrite microcristalline calcique (pseudo-goutte) chez un acromégale. Sem Hop. 1966 Oct 8;42(41):2420–2424. [PubMed] [Google Scholar]
  10. McCarty D. J., Pepe P. F. Erythrocyte neutral inorganic pyrophosphatase in pseudogout. J Lab Clin Med. 1972 Feb;79(2):277–284. [PubMed] [Google Scholar]
  11. McCarty D. J., Solomon S. D., Warnock M. L., Paloyan E. Inorganic pyrophosphate concentrations in the synovial fluid of arthritic patients. J Lab Clin Med. 1971 Aug;78(2):216–229. [PubMed] [Google Scholar]
  12. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  13. Russell R. G., Bisaz S., Donath A., Morgan D. B., Fleisch H. Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone. J Clin Invest. 1971 May;50(5):961–969. doi: 10.1172/JCI106589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Russell R. G., Bisaz S., Fleisch H., Currey H. L., Rubinstein H. M., Dietz A. A., Boussina I., Micheli A., Fallet G. Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout). Lancet. 1970 Oct 31;2(7679):899–902. doi: 10.1016/s0140-6736(70)92070-2. [DOI] [PubMed] [Google Scholar]
  15. Russell R. G., Bisaz S., Fleisch H. Pyrophosphate and diphosphonates in calcium metabolism and their possible role in renal failure. Arch Intern Med. 1969 Nov;124(5):571–577. [PubMed] [Google Scholar]
  16. SCHLESINGER M. J., COON M. J. Hydrolysis of nucleoside diand triphosphates by crystalline preparations of yeast inorganic pyrophosphatase. Biochim Biophys Acta. 1960 Jun 17;41:30–36. doi: 10.1016/0006-3002(60)90365-6. [DOI] [PubMed] [Google Scholar]
  17. SUGINO Y., MIYOSHI Y. THE SPECIFIC PRECIPITATION OF ORTHOPHOSPHATE AND SOME BIOCHEMICAL APPLICATIONS. J Biol Chem. 1964 Jul;239:2360–2364. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES